功能结局驱动根治性前列腺切除术后1年决策后悔:多中心前瞻性研究
该多中心前瞻性研究纳入德国和奥地利7个中心2022-2024年接受机器人辅助或耻骨后开放根治性前列腺切除术的局限期前列腺癌患者,术后1年完成决策后悔量表及功能结局问卷。结果显示决策后悔总体较低,但勃起功能障碍是最常被报告低于预期的结局,高泌尿症状负担和性功能受损独立预测高决策后悔,而手术方式与生化复发无此关联。
要点
- 根治性前列腺切除术后1年决策后悔总体较低,平均DRS评分9.0。
- 勃起功能障碍是最常被报告差于预期的结局(54%),其次为尿失禁(23%)。
- 高泌尿症状负担(OR 2.4)和性功能受损(OR 2.8)独立预测高决策后悔。
核心结论
- 根治性前列腺切除术后决策后悔主要由术后功能结局驱动,而非肿瘤学结果或手术方式。
- 优化功能恢复和管理患者期望是减少前列腺癌手术后悔的关键策略。
研究设计与样本
- 前瞻性多中心研究,纳入德国和奥地利7个中心2022-2024年接受机器人辅助或耻骨后开放根治性前列腺切除术的局限期前列腺癌患者。
- 共419例患者术后1年完成问卷(58%机器人辅助,42%开放手术)。
- 使用决策后悔量表评估后悔,EORTC QLQ-PR25症状评分评估功能结局,多因素logistic回归识别高决策后悔(DRS≥10)预测因素,并用倾向性评分匹配进行敏感性分析。
主要发现
- 决策后悔总体较低,平均DRS评分9.0(SD 15.4)。
- 患者回顾性感知中,勃起功能障碍是最常被报告差于预期的结局(54%,221/404),其次为尿失禁(23%,96/414)和肿瘤治愈(10%,39/397)。
- 开放手术患者对手术方式的后悔高于机器人辅助患者(平均DRS评分11.3 vs 7.4,P=0.02)。
- 多因素分析中,高泌尿症状负担(OR 2.4,P=0.009)和性功能受损(OR 2.8,P=0.002)独立预测高决策后悔,手术方式和前列腺特异性抗原复发无此关联。
- 倾向性评分匹配敏感性分析证实上述独立预测因素。
关键数值与推荐
- 高决策后悔定义为决策后悔量表评分≥10。
- 高泌尿症状负担预测高决策后悔的OR为2.4(P=0.009)。
- 性功能受损预测高决策后悔的OR为2.8(P=0.002)。
临床怎么用
- 术前应重点针对勃起功能和尿控预期进行充分沟通,以降低术后决策后悔。
- 术后应积极优化功能恢复,尤其关注泌尿症状和性功能。
- 手术方式选择本身不是决策后悔的主要驱动因素,不应过度强调术式对后悔的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To identify contemporary drivers of postoperative decision regret 1 year after radical prostatectomy (RP). PATIENTS AND METHODS: In this prospective, multicentre study, patients undergoing robot-assisted RP (RARP) or retropubic open RP (ORP) for localised prostate cancer at seven centres in Germany and Austria (2022-2024) completed questionnaires preoperatively and at 1 year postoperatively. Decision regret was assessed using the Decision Regret Scale (DRS). Functional outcomes were measured with European Organisation for Research and Treatment of Cancer quality of life questionnaire - 25-item prostate cancer specific (EORTC QLQ-PR25) symptom scores at 1 year postoperatively. Multivariable logistic regression identified predictors of high surgical decision regret (DRS score ≥10). Sensitivity was tested via propensity score matching (PSM). RESULTS: A total of 419 patients completed the surveys (58% RARP, 42% ORP) at 1 year postoperatively. Surgical decision regret was low (mean [SD] DRS score 9.0 [15.4]). Erectile dysfunction was the outcome that most patients self-reported as worse than expected (54% [221/404]), followed by urinary incontinence (23% [96/414]) and oncological cure (10% [39/397]) in a questionnaire on their retrospective perception. The ORP patients reported higher regret regarding surgical approach than RARP patients (mean [SD] DRS score 11.3 [17.1] vs 7.4 [13.9], P = 0.02). In a multivariate analysis, high urinary symptom burden (odds ratio [OR] 2.4, P = 0.009) and impaired sexual functioning (OR 2.8, P = 0.002) independently predicted high surgical decision regret whereas surgical approach and prostate-specific antigen recurrence did not. Sensitivity analyses via PSM confirmed these independent predictors. CONCLUSIONS: Surgical decision regret after RP is primarily driven by postoperative functional outcomes rather than oncological results or surgical approach. Optimising functional recovery and managing patient expectations are key strategies to reduce regret in prostate cancer surgery.
引用
- Hirtsiefer C, Kümmel E, Vogelgesang A, et al. Function drives 1-year decision regret in radical prostatectomy: a multicentre prospective study. BJU Int. 2026. PMID: 42429300. doi:10.1111/bju.70382
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。